Owners of BHP Group Ltd (ASX: BHP) shares can celebrate because the ASX mining share has risen 3%, and the BHP dividend has been announced.

The company revealed that revenue grew 15% to US$58.8 billion, profit from operations increased 23% to US$23.9 billion, underlying attributable profit grew 30% to US$13.2 billion, and attributable profit rose 9%.  

Profit generation funds the payment of dividends, so the fact that the company reported significant financial progress was a very helpful sign for the company to fund larger payouts.

Let’s look at how big the dividend payout will be.

BHP FY26 dividend

The ASX mining share wants to provide good passive income payments to shareholders.

The BHP board of directors declared an FY26 final dividend of US 99 cents, representing a 65% increase compared to the final dividend from FY25. That brought the full-year dividend to US$1.72, an increase of 56%.

These payouts mean the business is paying a total distribution of US$8.7 billion to owners of BHP shares, representing 66% of underlying attributable profit. BHP aims to provide investors with a minimum dividend payout ratio of 50% of underlying attributable profit for every reporting period.

Investors can utilise the dividend reinvestment plan (DRP) to receive the dividend as new BHP shares rather than cash.

When will the passive income be paid?

I’ll get to the dividend payment date in a moment, but first investors need to know about the ex-dividend date. Investors wanting to receive the payout need to own shares before the ex-dividend date or else they’ll miss out.

For the FY26 final dividend, BHP disclosed that the ex-dividend date is 3 September 2026, which is just over two weeks. That means investors need to own BHP shares by the end of trading on 2 September 2026 if they want to receive the upcoming payout.

After that date, the ASX mining share will pay its FY26 final dividend per share on 23 September 2026. That means investors only need to wait just over a month until the cash can hit their bank account.

If a shareholder wants to participate in the dividend reinvestment plan, they have until Monday, 7 September 2026 at 5pm to make that election.

What is the BHP dividend yield?

At the current BHP share price and exchange rate, the final dividend of US 99 cents is approximately AU$1.39. That’s a dividend yield of 2.2%, excluding franking credits, and 3.1%, including franking credits.

The full-year dividend of US$1.72 translates into approximately A$2.42. That equates to a dividend yield of 3.8%, excluding franking credits, and 5.4%, including franking credits.

That’s not one of the most exciting dividend yields around, so investors may want to also consider other ASX shares that could be attractive for passive dividend income.

The post Everything you need to know about the BHP dividend appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about CSL, Pro Medicus and BHP shares on Tuesday?
• How much do I need in my superannuation to earn $50,000 per year in passive income?
• How many BHP shares do I need to buy for $1,000 per month of passive income?
• BHP Group posts record FY26 earnings and flags copper-led future
• A200 vs NDQ: one Betashares ETF is the clear winner

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Xero Ltd (ASX: XRO) and Zip Co Ltd (ASX: ZIP) are two of the largest fintech shares listed on the ASX. 

Xero stands out of its cloud accounting and financial software, sticky subscriber based and huge growth opportunities. 

Meanwhile, buy now, pay later (BNPL) provider, Zip, stands out for its financially sound business model and aggressive expansion plans.

The other thing the two ASX 200 tech shares have in common is that they’ve both been smashed by an ongoing sector-wide sell-off, which sent their share prices crashing earlier this year.

But over the past month, the tide has turned for one of these tech powerhouses, and investors are reaping the rewards.

Let’s take a look.

Which ASX tech stock has made investors richer over the past month? 

Technology and growth shares have also come under renewed pressure recently as investors reassess valuations and risk appetite.

Both Xero and Zip shares suffered a share price crash late last year which continued through to early-2026.

While both stocks are still significantly lower than trading levels one year ago, when looking at the past month alone, Xero shares have far outperformed Zip shares.

Xero shares fell to around a seven-year low of $61.58 in late July, but have rebounded strongly since. At the time of writing, the shares have recovered around 32% from that point and are changing hands for $81.17 a piece. They’re also up 19% over the past month. 

Zip shares have had a much more volatile run. The shares dipped to an annual low of $1.45 in late-March and have rebounded around 79% ever since. But over the past month the shares have started falling again and are now down around 10%.

What do brokers tip next for Xero shares?

It looks like Xero shares are expected to continue their latest growth rally.

TradingView data shows that the majority (13 out of 15) have a buy/strong buy rating on Xero shares over the next 12 months.

The average $128.56 target price implies a potential 58% upside ahead, at the time of writing. But some think the shares have the potential to jump as much as 197% to $241.36 by this time next year.

What do brokers tip next for Zip shares?

While Zip shares have lagged behind Xero over the past month, the good news is that analysts forecasts are pretty similar.

TradingView data shows that the experts are also very bullish on the outlook for Zip shares. The majority (12 out of 13) have a buy/strong buy rating on the shares. 

The average $4.19 target price implies a potential 61% upside over the next 12 months. Although some think that Zip shares could increase another 115% to $5.59, at the time of writing.

The post Xero vs Zip shares: Which ASX 200 tech stock has made investors richer over the past month? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Bank of Queensland, Xero, PLS Group shares
• Experts name 3 popular ASX 200 shares to sell today
• 3 ASX tech shares with strong growth potential
• How an Australian could retire with $1 million in superannuation
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Pro Medicus Ltd (ASX: PME) shares have surged more than 10% on solid profit results, with the company saying its pipeline of inbound work is “very strong” going forward.

And at least one broker has a bullish share price target on the company, with Barrenjoey expecting the shares to appreciate to $210, up from $197.45 currently, up 12.3% on the day.

Pro Medicus profit increase in the double digits

The digital imaging software company reported full-year revenue of $261.7 million, up 22.9%, while underlying net profit was $144.7 million, up 24.1%.

Pro Medicus remains debt free with cash on hand of $252.3 million, and will pay a fully-franked final dividend of 37 cents per share, up from 30 cents.

On the operational front, the company said it had signed 10 new contracts worth a minimum of $407 million, and renewed six out of six existing contracts worth $141 million on five-year terms.

Pro Medicus Chief Executive Officer Dr Sam Hupert said the result was in line with expectations.

He added:

We were aiming for 30% increases in EBIT and NPAT, and we exceeded both on a constant currency basis. We continue to be able to address a broad range of market segments, with clients ranging from smaller sub specialised health systems through to some of the largest IDNs and academic medical centres in the US. Importantly, we have proven that with one platform and one business model we can address virtually every opportunity in diagnostic imaging, providing us with the largest total addressable market (TAM). Progress made in the cardiology market represents another important string to our bow. We see this trend continuing.

Pro Medicus to get an AI tailwind

Dr Hupert also said the company was becoming more convinced that AI would be a benefit.

He added:

I have always maintained that AI and healthcare are a strong match, particularly in diagnostic imaging, and we are starting to see examples of this emerging. We are ideally positioned to benefit from this transition as we are the radiologist’s desktop and therefore the gateway for the output of image-based AI. Our platform is now used by approximately 11% of the US market, including 11 out of the top 20 healthcare institutions in the US and growing. This gives us a very material base upon which we can layer AI, whether it is via our own algorithms, those we co-develop with our research partners or 3rd party algorithms.

During the year, the company invested $10 million in each of 4DMedical Ltd (ASX: 4DX) and Echo IQ Ltd (ASX: EIQ), which Dr Hupert said were strategic investments which had also done well from a return on capital perspective.

Pro Medicus is valued at $18.4 billion.

The post Why are Pro Medicus shares surging more than 10%? appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about CSL, Pro Medicus and BHP shares on Tuesday?
• Pro Medicus FY26: Strong earnings growth and higher dividend
• Reporting season half-time report: 5 lessons from August so far
• 5 things to watch on the ASX 200 on Tuesday
• How to build a strong ASX retirement portfolio with 10 shares

Motley Fool contributor Cameron England has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.